Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating exemestane with or without entinostat (SNDX-275) in postmenopausal women with advanced estrogen receptor-p…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial investigated fasting-mimicking dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative br…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating efficacy and tolerance of bevacizumab in Her2-negative inflammatory breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors [Phase 2]
Phase 2 trial assessing an oral bisphosphonate for osteopenic women treated with adjuvant aromatase inhibitors in breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] [Phase 3]
Phase 3 clinical trial update for the National Surgical Adjuvant Study of Breast Cancer (N-SAS BC) 07 RESPECT; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT [Phase 3]
Phase 3 trial evaluating whether oral care can prevent oral mucositis in ER-positive metastatic breast cancer patients treated with everolim…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating metformin to reduce cardiac toxicity in breast cancer; the study was terminated with results posted in 201…
-
FDA approval · 2019-10-10FDA Approved: CAPECITABINE 150MG — Supplemental Application (Armas Pharmaceuticals Inc.)
The FDA approved a supplemental application to add a 150 mg strength of capecitabine, manufactured by Armas Pharmaceuticals Inc., expanding …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction [Phase 3]
Phase 3 clinical trial evaluating Botulinum Toxin A (Botox) in tissue expander breast reconstruction has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment [Phase 2]
Phase 2 trial update evaluating the optimal duration of BP-C1 monotherapy in patients with metastatic breast cancer (Stage IV).
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for BP-C1 in short-term treatment of metastatic breast cancer (Stage IV) has completed.
-
FDA approval · 2019-10-09FDA Approved: CAPECITABINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Capecitabine (CAPECITABINE) from Ascend Laboratories, LLC under ANDA207652.
-
CLINICAL_TRIALS research · 2019-10-09Clinical Trial Update: Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms? [NA]
Clinical trial updating on chemotherapy-induced peripheral neuropathy and whether physical therapy may help alleviate symptoms; completed wi…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating 0.1% Uracil Topical Cream for prevention of hand-foot syndrome in breast cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy with trastuzumab in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update on BP-C1 for short-term treatment in Thai patients with metastatic/metastatic breast cancer (Stage IV) has b…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy [Phase 4]
Phase 4 trial update comparing pectoral nerve block to local anesthetic infiltration for analgesia after mastectomy in breast cancer patient…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with radiotherapy for metastatic triple-negative breast cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
A completed clinical trial evaluating CK19 combined with contrast-enhanced ultrasound as a predictive system for axillary lymph node metasta…
-
FDA approval · 2019-10-03FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for gemcitabine hydrochloride from Gland Pharma Limited. This approval enables the marketing of …
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation [Phase 3]
Phase 3 trial comparing mometasone furoate 0.1% to Eucerin for skin toxicities in breast cancer patients receiving postmastectomy radiation;…
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF [Phase 3]
Phase 3 trial comparing an epirubicin/cyclophosphamide regimen followed by docetaxel versus six-cycle CMF/CEF in breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Secondary Adjuvant Long Term Study With Arimidex [Phase 3]
Phase 3 long-term secondary adjuvant trial of Arimidex in breast cancer has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer [Phase 2]
Phase 2 clinical trial assessing high-dose tamoxifen in advanced hormone receptor-high expressed breast cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) [Phase 3]
Phase 3 trial update comparing trastuzumab emtansine (T-DM1) to trastuzumab as adjuvant therapy in HER2-positive breast cancer with residual…